acyclovir

Generic: acyclovir

Labeler: zydus lifesciences limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir
Generic Name acyclovir
Labeler zydus lifesciences limited
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

acyclovir sodium 50 mg/mL

Manufacturer
Zydus Lifesciences Limited

Identifiers & Regulatory

Product NDC 70771-1384
Product ID 70771-1384_0e2d2e97-1c08-4ae1-be53-ec77eb909a89
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206535
Listing Expiration 2026-12-31
Marketing Start 2018-11-27

Pharmacologic Class

Classes
dna polymerase inhibitors [moa] herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc] nucleoside analog [ext]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707711384
Hyphenated Format 70771-1384

Supplemental Identifiers

RxCUI
1734932 1734934
UNII
927L42J563

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir (source: ndc)
Generic Name acyclovir (source: ndc)
Application Number ANDA206535 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 50 mg/mL
source: ndc
Packaging
  • 10 VIAL, SINGLE-USE in 1 CARTON (70771-1384-6) / 20 mL in 1 VIAL, SINGLE-USE (70771-1384-1)
source: ndc

Packages (1)

Ingredients (1)

acyclovir sodium (50 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "0e2d2e97-1c08-4ae1-be53-ec77eb909a89", "openfda": {"unii": ["927L42J563"], "rxcui": ["1734932", "1734934"], "spl_set_id": ["383b930b-6e9c-4ac9-a078-baac6276f340"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-USE in 1 CARTON (70771-1384-6)  / 20 mL in 1 VIAL, SINGLE-USE (70771-1384-1)", "package_ndc": "70771-1384-6", "marketing_start_date": "20181127"}], "brand_name": "acyclovir", "product_id": "70771-1384_0e2d2e97-1c08-4ae1-be53-ec77eb909a89", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70771-1384", "generic_name": "ACYCLOVIR", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA206535", "marketing_category": "ANDA", "marketing_start_date": "20181127", "listing_expiration_date": "20261231"}